1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Comprehensive comparison of homologous recombination deficiency predictors in early-stage triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Genome-Wide DNA Methylation Profiling of Triple-Negative Breast Cancer Uncovers Epigenetic Biomarkers of Tumor Identity and the Immune Microenvironment
- Contribution to journal › Article
- 2025
-
Mark
Stand-alone transcriptional immune response prediction in primary triple-negative breast cancer
- Contribution to journal › Article
- 2024
-
Mark
Tumor purity estimated from bulk DNA methylation can be used for adjusting beta values of individual samples to better reflect tumor biology
- Contribution to journal › Article
